Annual D&A
$3.42 M
-$2.30 M-40.25%
December 1, 2023
Summary
- As of February 7, 2025, PTPI annual depreciation & amortization is $3.42 million, with the most recent change of -$2.30 million (-40.25%) on December 1, 2023.
- During the last 3 years, PTPI annual D&A has fallen by -$3.25 million (-48.72%).
- PTPI annual D&A is now -50.35% below its all-time high of $6.88 million, reached on December 31, 2021.
Performance
PTPI Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$768.30 K
+$13.60 K+1.80%
September 1, 2024
Summary
- As of February 7, 2025, PTPI quarterly depreciation & amortization is $768.30 thousand, with the most recent change of +$13.60 thousand (+1.80%) on September 1, 2024.
- Over the past year, PTPI quarterly D&A has dropped by -$92.00 thousand (-10.69%).
- PTPI quarterly D&A is now -55.56% below its all-time high of $1.73 million, reached on March 31, 2021.
Performance
PTPI Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$3.11 M
-$92.00 K-2.87%
September 1, 2024
Summary
- As of February 7, 2025, PTPI TTM depreciation & amortization is $3.11 million, with the most recent change of -$92.00 thousand (-2.87%) on September 1, 2024.
- Over the past year, PTPI TTM D&A has dropped by -$497.60 thousand (-13.78%).
- PTPI TTM D&A is now -54.73% below its all-time high of $6.88 million, reached on December 31, 2021.
Performance
PTPI TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
PTPI Depreciation And Amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -40.3% | -10.7% | -13.8% |
3 y3 years | -48.7% | -10.5% | -37.9% |
5 y5 years | -35.5% | -10.5% | -37.9% |
PTPI Depreciation And Amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -50.4% | at low | -54.6% | +2.0% | -54.7% | at low |
5 y | 5-year | -50.4% | at low | -55.6% | +2.0% | -54.7% | +87.4% |
alltime | all time | -50.4% | at low | -55.6% | +2.0% | -54.7% | +87.4% |
Petros Pharmaceuticals Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $768.30 K(+1.8%) | $3.11 M(-2.9%) |
Jun 2024 | - | $754.70 K(+0.2%) | $3.21 M(-3.2%) |
Mar 2024 | - | $753.50 K(-10.0%) | $3.31 M(-3.1%) |
Dec 2023 | $3.42 M(-40.3%) | $837.20 K(-2.7%) | $3.42 M(-5.4%) |
Sep 2023 | - | $860.30 K(+0.1%) | $3.61 M(-16.2%) |
Jun 2023 | - | $859.30 K(+0.1%) | $4.31 M(-14.0%) |
Mar 2023 | - | $858.30 K(-16.9%) | $5.01 M(-12.3%) |
Dec 2022 | $5.72 M | $1.03 M(-33.8%) | $5.72 M(-10.3%) |
Sep 2022 | - | $1.56 M(0.0%) | $6.37 M(-2.6%) |
Jun 2022 | - | $1.56 M(0.0%) | $6.54 M(-2.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | $1.56 M(-7.7%) | $6.71 M(-2.4%) |
Dec 2021 | $6.88 M(+3.3%) | $1.69 M(-2.2%) | $6.88 M(+0.2%) |
Sep 2021 | - | $1.73 M(0.0%) | $6.86 M(+1.0%) |
Jun 2021 | - | $1.73 M(0.0%) | $6.80 M(+1.0%) |
Mar 2021 | - | $1.73 M(+3.1%) | $6.73 M(+1.0%) |
Dec 2020 | $6.66 M(+25.9%) | $1.68 M(+0.9%) | $6.66 M(+33.6%) |
Sep 2020 | - | $1.66 M(0.0%) | $4.98 M(+50.0%) |
Jun 2020 | - | $1.66 M(0.0%) | $3.32 M(+100.0%) |
Mar 2020 | - | $1.66 M | $1.66 M |
Dec 2019 | $5.29 M | - | - |
FAQ
- What is Petros Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Petros Pharmaceuticals?
- What is Petros Pharmaceuticals annual D&A year-on-year change?
- What is Petros Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Petros Pharmaceuticals?
- What is Petros Pharmaceuticals quarterly D&A year-on-year change?
- What is Petros Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Petros Pharmaceuticals?
- What is Petros Pharmaceuticals TTM D&A year-on-year change?
What is Petros Pharmaceuticals annual depreciation & amortization?
The current annual D&A of PTPI is $3.42 M
What is the all time high annual D&A for Petros Pharmaceuticals?
Petros Pharmaceuticals all-time high annual depreciation & amortization is $6.88 M
What is Petros Pharmaceuticals annual D&A year-on-year change?
Over the past year, PTPI annual depreciation & amortization has changed by -$2.30 M (-40.25%)
What is Petros Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of PTPI is $768.30 K
What is the all time high quarterly D&A for Petros Pharmaceuticals?
Petros Pharmaceuticals all-time high quarterly depreciation & amortization is $1.73 M
What is Petros Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, PTPI quarterly depreciation & amortization has changed by -$92.00 K (-10.69%)
What is Petros Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of PTPI is $3.11 M
What is the all time high TTM D&A for Petros Pharmaceuticals?
Petros Pharmaceuticals all-time high TTM depreciation & amortization is $6.88 M
What is Petros Pharmaceuticals TTM D&A year-on-year change?
Over the past year, PTPI TTM depreciation & amortization has changed by -$497.60 K (-13.78%)